• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

委员会意见 No.477:妇产科医生在早期发现上皮性卵巢癌中的作用。

Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer.

出版信息

Obstet Gynecol. 2011 Mar;117(3):742-746. doi: 10.1097/AOG.0b013e31821477db.

DOI:10.1097/AOG.0b013e31821477db
PMID:21343791
Abstract

Epithelial ovarian cancer is most commonly detected in an advanced stage, when the overall 5-year survival rate is 20–30%. Detection of early-stage ovarian cancer results in improved survival. Currently, there is no effective strategy for ovarian cancer screening. Women with persistent and progressive symptoms, such as an increase in bloating, pelvic or abdominal pain, or difficulty eating or feeling full quickly, should be evaluated, with ovarian cancer being included in the differential diagnosis. Evaluation of the symptomatic patient includes physical examination and may include transvaginal ultrasonography and measurement of levels of the serum tumor marker CA 125. Patients suspected of having ovarian cancer should be managed by a gynecologic surgeon, such as a gynecologic oncologist, who is trained to perform comprehensive surgical staging and cytoreductive (debulking) surgery.

摘要

上皮性卵巢癌在晚期最为常见,此时总体 5 年生存率为 20-30%。早期卵巢癌的检测可提高生存率。目前,尚无有效的卵巢癌筛查策略。对于持续且进展的症状(如腹胀、盆腔或腹部疼痛、或进食或饱腹感迅速增加)的女性,应进行评估,包括卵巢癌在内的鉴别诊断。有症状患者的评估包括体格检查,可能包括经阴道超声检查和血清肿瘤标志物 CA 125 水平的测量。疑似患有卵巢癌的患者应由妇科外科医生(如妇科肿瘤学家)进行管理,其接受过全面的外科分期和细胞减灭术(肿瘤减灭术)的培训。

相似文献

1
Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer.委员会意见 No.477:妇产科医生在早期发现上皮性卵巢癌中的作用。
Obstet Gynecol. 2011 Mar;117(3):742-746. doi: 10.1097/AOG.0b013e31821477db.
2
ACOG Committee Opinion: number 280, December 2002. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer.美国妇产科医师学会委员会意见:第280号,2002年12月。普通妇产科医生在卵巢癌早期检测中的作用。
Obstet Gynecol. 2002 Dec;100(6):1413-6. doi: 10.1016/s0029-7844(02)02630-3.
3
The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer.全科妇产科医生在卵巢癌早期检测中的作用。
Int J Gynaecol Obstet. 2003 Feb;80(2):235-8. doi: 10.1016/s0020-7292(03)00022-5.
4
The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer.全科妇产科医生在卵巢癌早期检测中的作用。
Gynecol Oncol. 2002 Dec;87(3):237-9. doi: 10.1006/gyno.2002.6865.
5
Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.委员会意见 No. 716 概要:妇产科医生在平均风险女性上皮性卵巢癌的早期检测中的作用。
Obstet Gynecol. 2017 Sep;130(3):664-665. doi: 10.1097/AOG.0000000000002289.
6
Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.委员会意见 No.716:妇产科医生在平均风险女性上皮性卵巢癌的早期检测中的作用。
Obstet Gynecol. 2017 Sep;130(3):e146-e149. doi: 10.1097/AOG.0000000000002299.
7
HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study.人附睾蛋白4(HE4)、癌抗原125(CA125)及卵巢恶性肿瘤风险算法(ROMA)作为盆腔肿块患者卵巢癌诊断工具的意大利多中心研究。
Gynecol Oncol. 2016 May;141(2):303-311. doi: 10.1016/j.ygyno.2016.01.016. Epub 2016 Jan 19.
8
Clinical study of a CT evaluation model combined with serum CA125 in predicting the treatment of newly diagnosed advanced epithelial ovarian cancer.CT 评价模型联合血清 CA125 预测初治晚期上皮性卵巢癌治疗效果的临床研究
J Ovarian Res. 2018 Jun 18;11(1):49. doi: 10.1186/s13048-018-0422-z.
9
Ovarian cancer: screening, treatment, and followup.卵巢癌:筛查、治疗及随访
NIH Consens Statement. 1994;12(3):1-30.
10
Results of Primary Cytoreductive Surgery in Advanced-stage Epithelial Ovarian Cancer: A Single-center Experience.晚期上皮性卵巢癌初次肿瘤细胞减灭术的结果:单中心经验
Anticancer Res. 2015 Jul;35(7):4099-104.

引用本文的文献

1
Clinical Evaluation of a Multi-Omic Diagnostic Model for Early-Stage Ovarian Cancer Detection.用于早期卵巢癌检测的多组学诊断模型的临床评估
Diagnostics (Basel). 2025 Sep 2;15(17):2225. doi: 10.3390/diagnostics15172225.
2
When it's not ovarian cancer: A case of a massive leiomyoma with hydropic change.非卵巢癌病例:一例伴有水肿样变的巨大平滑肌瘤
Gynecol Oncol Rep. 2024 May 11;53:101415. doi: 10.1016/j.gore.2024.101415. eCollection 2024 Jun.
3
Sertoliform endometrioid carcinoma of the right ovary.右卵巢塞尔托利样子宫内膜样癌
Endocrinol Diabetes Metab Case Rep. 2023 Sep 28;2023(3). doi: 10.1530/EDM-23-0046. Print 2023 Jul 1.
4
Diagnostic accuracy of the Copenhagen Index in ovarian malignancy: A meta-analysis.《哥本哈根指数在卵巢恶性肿瘤中的诊断准确性:一项荟萃分析》。
PLoS One. 2023 Jun 14;18(6):e0286650. doi: 10.1371/journal.pone.0286650. eCollection 2023.
5
Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer.外泌体微小RNA在卵巢癌诊断与治疗中的研究进展
Discov Oncol. 2023 May 10;14(1):65. doi: 10.1007/s12672-023-00674-7.
6
Clinical Performance of a Multivariate Index Assay in Detecting Early-Stage Ovarian Cancer in Filipino Women.一种多变量指数检测在菲律宾女性早期卵巢癌检测中的临床性能。
Int J Environ Res Public Health. 2022 Aug 11;19(16):9896. doi: 10.3390/ijerph19169896.
7
Ovarian mass-differentiating benign from malignant. Why the International Ovarian Tumour Analysis rules should be implemented in Australasia.卵巢肿块——鉴别良恶性。为何应在澳大拉西亚地区实施国际卵巢肿瘤分析规则。
Australas J Ultrasound Med. 2018 Aug 22;21(3):121-124. doi: 10.1002/ajum.12108. eCollection 2018 Aug.
8
A Comparative Study between 18F-FDG PET/CT and Conventional Imaging in the Evaluation of Progressive Disease and Recurrence in Ovarian Carcinoma.18F-FDG PET/CT与传统成像技术在评估卵巢癌疾病进展和复发中的比较研究
Healthcare (Basel). 2021 Jun 3;9(6):666. doi: 10.3390/healthcare9060666.
9
An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy.基于尿液生物标志物和新型验证策略的卵巢癌改良预测模型。
Int J Mol Sci. 2019 Oct 5;20(19):4938. doi: 10.3390/ijms20194938.
10
Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors.RMI 的诊断扩展用途:比较四种卵巢肿瘤交界性和良性肿瘤术前鉴别风险的恶性指数。
J Ovarian Res. 2019 Sep 16;12(1):87. doi: 10.1186/s13048-019-0568-3.